
Join to view full profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Maron is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Maron is the C.F. Rehnborg Professor of Medicine and Chief of the Stanford Prevention Research Center at Stanford University. He received his undergraduate degree from Stanford and his medical degree from the University of Southern California. He trained in internal medicine at UCLA, then returned to Stanford where he was a Robert Wood Johnson Clinical Scholar. He remained at Stanford to complete cardiology fellowship training. After a brief stint in private practice in Santa Monica, he joined the faculty at Vanderbilt in 1993 as Director of Preventive Cardiology and rose through the ranks to Professor. He returned to Stanford in 2014.
Dr. Maron’s research is focused on the primary and secondary prevention of coronary artery disease. He was a member of the team that designed the VA-funded COURAGE trial that tested the benefit of PCI added to guideline-directed medical therapy in patients with stable coronary artery disease. He was co-chair and principal investigator of the ISCHEMIA trial, an NIH-funded study that tested the benefits of an initial invasive approach compared with a conservative approach in patients with stable coronary artery disease. He is co-chair of the TRANSFORM trial comparing conventional risk factor-based care with atherosclerosis stage-based care in a high-risk asymptomatic population.
He helped develop an AI algorithm to measure coronary artery calcium in nongated chest CT scans. This algorithm is used in over 100 hospitals for opportunistic screening for incidental coronary artery calcium. He sees patients in the Stanford Preventive Cardiology clinic and is president-elect of the American Society for Preventive Cardiology.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1989 - 1991
Stanford Health CareResidency, Preventive Cardiology Fellowship and Robert Wood Johnson Clinical Scholar, 1984 - 1986
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1981 - 1984
Keck School of Medicine of the University of Southern CaliforniaClass of 1981
Certifications & Licensure
CA State Medical License 1982 - 2027
TN State Medical License 1993 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification StarPanel, Vanderbilt University, 2012, 2014, 2016-2017
- Fellow (FACC) American College of Cardiology
Clinical Trials
- International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
- NOTIFY (New Observations Taking Information From Yesterday) Start of enrollment: 2026 Mar 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Clinical outcomes among individuals with systemic inflammation following myocardial infarction: Insights from the veterans affairs healthcare system.Alexander T Sandhu, Adam Furst, Fatima Rodriguez, Neil Kalwani, David J Maron
American Journal of Preventive Cardiology. 2026-10-01 - Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease.Matthew Muller, MacIntosh G Cornwell, Sandhya Rajkumar, Ze Chen, David Coit
Nature Communications. 2026-06-16 - Association Between Predicting Risk of Cardiovascular Disease Events (PREVENT) Risk Scores and Subclinical Cardiovascular Disease: Insights From the Project Baseline H...Gracia Fahed, Diona Gjermeni, Nicholas Cauwenberghs, Everton J Santana, Bettia E Celestin
Journal of the American Heart Association. 2026-06-02
Journal Articles
- Initial Invasive or Conservative Strategy for Stable Coronary DiseaseDavid Maron, MD, The New England Journal of Medicine
- Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe IschemiaMichael H Picard, Raymond Y Kwong, William E Boden, David J Maron, Judith S Hochman, JAMA Cardiology
Lectures
- Preview From the Upcoming Ischemia TrialCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Personal Position Statement: “Patients With Stable Ischemic Heart Disease Are Best Managed Conservatively Until Truly Refractory Symptoms Develop2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Authored Content
- Initial Invasive or Conservative Strategy for Stable Coronary DiseaseApril 2020
- Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe IschemiaMarch 2020
Press Mentions
A Promising Heart Drug Fails, Challenging a Long-Held Theory of DiseaseAugust 6th, 2026
HeartLung Technologies Sets New Milestone with Nine Accepted Abstracts at AHA 2025 Showcasing the Power of AI-CVD™October 22nd, 2025
6 Drinks You Should Never Mix with Blood Pressure MedicationsSeptember 18th, 2025
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








